Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated NPM1 and TET2.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Nov 2022
Historique:
pubmed: 22 2 2022
medline: 8 11 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

Bone marrow necrosis (BMN) has various underlying diseases. In hematological malignancies, both lymphoid and myeloid neoplasms have been shown to cause BMN. Charcot-Leyden crystals (CLCs) are bipyramidal crystals that have been found in patients with immune system diseases, tumors, skin diseases, asthma, infections, and intestinal diseases. Because the combination of CLCs and acute myeloid leukemia (AML) is rare, the relationship between BMN, CLCs, and AML remains largely unexplored. We herein report a suspected case of AML that was difficult to diagnose morphologically because of complete BMN with CLCs but achieved complete hematologic remission with treatment similar to that for AML.

Identifiants

pubmed: 35185048
doi: 10.2169/internalmedicine.8859-21
pmc: PMC9683816
doi:

Substances chimiques

Dioxygenases EC 1.13.11.-
DNA-Binding Proteins 0
Nuclear Proteins 0
TET2 protein, human EC 1.13.11.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3265-3269

Références

Int J Hematol. 2015 Sep;102(3):349-56
pubmed: 26185062
Int J Lab Hematol. 2019 Oct;41(5):585-592
pubmed: 31424633
Int J Lab Hematol. 2015 Aug;37(4):e100-2
pubmed: 25754678
Cancer. 2000 Apr 15;88(8):1769-80
pubmed: 10760751
J Dermatol Sci. 1998 Jul;17(3):198-204
pubmed: 9697048
J Immunol. 2019 Jan 15;202(2):550-558
pubmed: 30559319
Int J Hematol. 2013 Sep;98(3):267-8
pubmed: 23884732
Am J Clin Pathol. 2015 Feb;143(2):201-13; quiz 306
pubmed: 25596246
Am J Hematol. 2002 Aug;70(4):300-5
pubmed: 12210811
Molecules. 2018 Nov 09;23(11):
pubmed: 30424011
Thromb J. 2016 Sep 28;14:42
pubmed: 27708553
Leuk Res. 2010 Dec;34(12):e336-8
pubmed: 20956014
Stem Cells. 1998;16(1):16-24
pubmed: 9474744
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e356-e364
pubmed: 33541793

Auteurs

Kenki Saito (K)

Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.

Takayuki Sato (T)

Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.

Kenji Notohara (K)

Department of Anatomic Pathology, Kurashiki Central Hospital, Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology, Kyoto University, Japan.
Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Kyoto University, Japan.

Yasunori Ueda (Y)

Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH